By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Repros Therapeutics Inc. 

2408 Timberloch Place
Suite B-7
The Woodlands  Texas  77380  U.S.A.
Phone: 281-719-3400 Fax: 281-719-3446


SEARCH JOBS








Company News
Repros Therapeutics (RPRX) Reports Second Quarter 2017 Financial Results 8/14/2017 7:27:26 AM
No Relief For Investors As The FDA Keeps Partial Hold On Repros Therapeutics (RPRX)'s Proellex Program 7/17/2017 6:35:58 AM
Repros Therapeutics (RPRX) Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock 5/18/2017 11:16:48 AM
Repros Therapeutics (RPRX) Announces Pricing Of $3 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock 5/18/2017 10:17:01 AM
Repros Therapeutics (RPRX) Reports First Quarter 2017 Financial Results 5/10/2017 12:07:33 PM
Repros Therapeutics (RPRX) Announces The Issuance Of New U.S. Patent Relating To Treatment Using Off Drug Intervals For Certain Uterine Conditions 4/17/2017 8:07:54 AM
Repros Therapeutics (RPRX) Release: Company Holds Meeting With FDA To Discuss Oral Proellex In The Treatment Of Uterine Fibroids 4/10/2017 9:21:51 AM
Repros Therapeutics (RPRX) Names Larry Dillaha, M.D., Its Permanent President And CEO 4/10/2017 9:13:52 AM
Repros Therapeutics (RPRX) Reports Fourth Quarter And Year End 2016 Financial Results 3/31/2017 6:57:21 AM
Repros Therapeutics (RPRX) Boss Steps Down, Interim CEO Named 2/2/2017 8:09:36 AM
12345678910...
//-->